|
EBAG9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.170020E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.910990E-01 |
| Normal-vs-Stage2 |
9.876800E-01 |
| Normal-vs-Stage3 |
1.420840E-03 |
| Normal-vs-Stage4 |
3.014500E-04 |
| Stage1-vs-Stage2 |
4.392400E-01 |
| Stage1-vs-Stage3 |
9.978300E-03 |
| Stage1-vs-Stage4 |
3.875100E-03 |
| Stage2-vs-Stage3 |
2.225900E-02 |
| Stage2-vs-Stage4 |
1.247540E-02 |
| Stage3-vs-Stage4 |
6.640200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.425500E-02 |
| Normal-vs-AfricanAmerican |
6.39919999999572E-05 |
| Normal-vs-Asian |
3.329600E-01 |
| Caucasian-vs-AfricanAmerican |
5.979600E-03 |
| Caucasian-vs-Asian |
9.095400E-01 |
| AfricanAmerican-vs-Asian |
3.448800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.084600E-03 |
| Normal-vs-Female |
9.892200E-02 |
| Male-vs-Female |
3.670800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.753500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.646000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.730200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.322800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.499600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.626300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.632200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.852600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.275600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.500600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.217600E-01 |
| Normal-vs-Grade 2 |
9.407000E-01 |
| Normal-vs-Grade 3 |
1.063660E-03 |
| Normal-vs-Grade 4 |
4.81690000109225E-08 |
| Grade 1-vs-Grade 2 |
9.506600E-01 |
| Grade 1-vs-Grade 3 |
8.861900E-02 |
| Grade 1-vs-Grade 4 |
3.078800E-03 |
| Grade 2-vs-Grade 3 |
1.447500E-04 |
| Grade 2-vs-Grade 4 |
1.11600000352041E-08 |
| Grade 3-vs-Grade 4 |
4.237000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.055000E-01 |
| Normal-vs-ccB subtype |
9.64930000000308E-05 |
| ccA subtype-vs-ccB subtype |
5.94429999667412E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.426070E-02 |
| Normal-vs-N1 |
1.365370E-04 |
| N0-vs-N1 |
4.074400E-02 |
|
|
